Total reported value
$50.7M
Reporting period: 2021-09-30 · Number of holdings: 25
Healthcare Value Capital, LLC disclosed 25 holdings in its latest 13F filing for the period ending 2021-09-30, with total reported value of $50.7M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "H"
No holding changes this quarter
Showing top 23 holdings (of 25 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALKS | Alkermes plc | Stock-Healthcare | 12.18% | — | +33.33% | |
| 2 | PFE | Pfizer INC | Stock-Healthcare | 10.62% | — | +25.00% | |
| 3 | GILD | Gilead Sciences INC | Stock-Healthcare | 8.27% | — | -20.00% | |
| 4 | GSK | GSK plc ADRhedged | Stock-Healthcare | 7.54% | — | — | |
| 5 | ✓ | Amryt Pharma LTD - Spnr Adr | Stock-Other | 5.97% | — | +25.00% | |
| 6 | MRK | Merck & Co. INC. | Stock-Healthcare | 5.93% | — | — | |
| 7 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 5.93% | — | — | |
| 8 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 5.84% | — | — | |
| 9 | SPXU | ProShares UltraPro Short S&P500 | Stock-Other | 5.19% | — | +200.00% | |
| 10 | IRWD | Ironwood Pharmaceuticals INC | Stock-Other | 5.16% | — | -20.00% | |
| 11 | CLVSEUR | Clovis Oncology INC | Stock-Other | 4.40% | — | — | |
| 12 | TYMEUSD | Tyme Technologies INC | Stock-Other | 4.07% | — | +33.33% | |
| 13 | ATRSEUR | Antares Pharma INC | Stock-Other | 3.59% | — | — | |
| 14 | ✓ | Proshares Ultrapro Short Qqq | Stock-Other | 3.41% | — | +100.00% | |
| 15 | UVXYN | Proshares Ultra Vix St Futur | ETF-Other | 2.42% | — | — | |
| 16 | ✓ | Amarin Corp PLC | Stock-Other | 2.01% | — | — | |
| 17 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 1.79% | — | — | |
| 18 | ✓ | Greenlane Holdings INC A | Stock-Other | 1.64% | — | — | |
| 19 | MNLOUSD | Vyne Therapeutics INC | Stock-Other | 1.10% | — | -11.11% | |
| 20 | ADMSEUR | Adamas Pharmaceuticals INC | Stock-Other | 0.97% | — | — | |
| 21 | ✓ | Gamida Cell LTD | Stock-Other | 0.77% | — | +33.33% | |
| 22 | DRRXEUR | Durect Corporation | Stock-Other | 0.63% | — | — | |
| 23 | ✓ | Proshares Tr Ii | Stock-Other | 0.56% | — | -50.00% |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2021-09-30 | 25 | $50.7M | 0 | |
| 2021-06-30 | 23 | $50.2M | 94 | |
| 2021-03-31 | 22 | $44.9M | 100 | |
| 2020-12-31 | 17 | $29.7M | 35 | |
| 2020-09-30 | 18 | $30.3M | 67 | |
| 2020-06-30 | 19 | $39.2M | 56 | |
| 2020-03-31 | 26 | $59.5M | 90 | |
| 2019-12-31 | 16 | $34.0M | 68 | |
| 2019-09-30 | 22 | $55.4M | 81 | |
| 2019-06-30 | 19 | $53.3M | 100 | |
| 2019-03-31 | 10 | $26.0M | 91 | |
| 2018-12-31 | 10 | $25.7M | 68 | |
| 2018-09-30 | 12 | $41.3M | 31 | |
| 2018-06-30 | 13 | $35.3M | 41 | |
| 2018-03-31 | 9 | $24.1M | 50 | |
| 2017-12-31 | 11 | $32.9M | 55 | |
| 2017-09-30 | 13 | $50.0M | 68 | |
| 2017-06-30 | 17 | $55.7M | 46 | |
| 2017-03-31 | 19 | $58.5M | 67 | |
| 2016-12-31 | 20 | $93.3M | 100 | |
| 2016-09-30 | 20 | $63.1M | 66 | |
| 2016-06-30 | 26 | $82.5M | 58 | |
| 2016-03-31 | 30 | $68.1M | 40 | |
| 2015-12-31 | 22 | $60.5M | 43 | |
| 2015-09-30 | 28 | $70.1M | 59 | |
| 2015-06-30 | 30 | $95.2M | 79 | |
| 2015-03-31 | 36 | $91.8M | 57 | |
| 2014-12-31 | 26 | $54.7M | 87 | |
| 2014-09-30 | 32 | $103.6M | 76 | |
| 2014-06-30 | 33 | $119.2M | 63 | |
| 2014-03-31 | 45 | $152.9M | 89 | |
| 2013-12-31 | 36 | $136.3M | 73 | |
| 2013-09-30 | 50 | $114.4M | 70 | |
| 2013-06-30 | 56 | $137.9M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
Institutions with a similar AUM
CIK 0001519462
Total reported value
$50.7M
2 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001534450
Total reported value
$50.7M
122 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001462014
Total reported value
$50.7M
1 stks
2022-09-30
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001542108
Total reported value
$1.3B
204 stks
2026-03-31
2 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
1 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0000275216
Total reported value
$11.6B
1,648 stks
2015-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Gilead Sciences INC